Library / Laws / 117th Congress / Senate Bills / S. 4302
S. 4302
To amend the Federal Food, Drug, and Cosmetic Act to require prompt reports of marketing status by holders of approved applications for biological products, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2022-05-25 | 4.5K | ⠃⠗⠋ |